Using an experimental model of airway allergic inflammation in mice, DNAhsp65 immunotherapy attenuated eosinophilia, IgE production, pulmonary inflammation, airway hyperresponsiveness, Th2 cytokines, and mucus production (80). The gene discussed is IGHE; the disease is Increased total eosinophil count.